ExploreWatchlistsPricing
  1. JP-listed companies
  2. SYSMEX CORPORATION
  3. Financials
  4. Short-term debt

SYSMEX CORPORATION (6869)

Market cap
¥901.4B
P/E ratio
21.8x
Develops and manufactures medical testing equipment and reagents for blood tests and urinalysis, serving healthcare institutions worldwide.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndShort-term debt (Million JPY)YoY (%)
Mar 31, 20251,403+36.48%
Mar 31, 20241,028-70.94%
Mar 31, 20233,537+138.66%
Mar 31, 20221,482-3.07%
Mar 31, 20211,529+176.99%
Mar 31, 2020552-31.51%
Mar 31, 2019806-89.40%
Mar 31, 20187,607+7.90%
Mar 31, 20177,050-42.73%
Mar 31, 201612,311-12.45%
Mar 31, 201514,061

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat